B16.2 Acute hepatitis B without delta-agent with hepatic coma

Name of the Condition

• Acute hepatitis B without delta-agent with hepatic coma

Summary

Acute hepatitis B without delta-agent with hepatic coma is a severe viral infection characterized by liver inflammation caused by the hepatitis B virus (HBV), leading to hepatic coma. This condition involves acute liver failure and impaired consciousness due to severe liver dysfunction. Unlike cases with the delta agent, this diagnosis specifies the absence of HDV co-infection, which typically results in more aggressive disease progression.

Causes

Acute hepatitis B without delta-agent with hepatic coma is caused by the hepatitis B virus (HBV), a DNA virus that infects liver cells. The virus spreads through contact with infectious blood or bodily fluids, including unprotected sexual contact, sharing needles, or perinatal transmission from an infected mother to her newborn. The absence of the delta agent (HDV) distinguishes this condition from co-infection cases, though HBV alone can still cause severe liver damage leading to hepatic coma.

Risk Factors

• Unprotected sexual contact with an infected person
• Sharing needles or syringes for drug use
• Occupational exposure to blood (e.g., healthcare workers)
• Living in close contact with someone who has chronic HBV
• Travel to regions with high HBV prevalence
• Receiving blood transfusions or organ transplants in areas with inadequate screening

Symptoms

• Severe fatigue and malaise
• Jaundice (yellowing of the skin and eyes)
• Hepatic coma (impaired consciousness due to liver failure)
• Abdominal pain and swelling
• Dark urine or clay-colored stools
• Nausea, vomiting, or loss of appetite

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests to detect HBV markers (e.g., HBsAg, anti-HBc IgM), and assessment of liver function. Imaging or liver biopsy may be used to evaluate liver damage. The absence of delta agent (HDV) is confirmed through specific serologic testing. Hepatic coma is diagnosed based on clinical signs of severe liver failure, such as altered mental status or encephalopathy.

Treatment Options

Treatment focuses on supportive care, including monitoring for complications, managing symptoms, and addressing liver failure. Antiviral medications (e.g., nucleos(t)ide analogs) may be used to reduce viral replication. In severe cases, liver transplantation may be necessary. Management of hepatic coma involves addressing precipitating factors (e.g., infection, electrolyte imbalances) and providing intensive care support.

Prognosis and Follow-Up

Prognosis depends on the severity of liver damage and response to treatment. Some patients may recover with supportive care, while others may progress to chronic hepatitis or require liver transplantation. Follow-up includes regular monitoring of liver function, viral load, and clinical status to assess recovery or detect complications. Long-term care may be needed for persistent liver dysfunction.

Complications

• Acute liver failure
• Hepatic coma (impaired consciousness)
• Chronic hepatitis B infection
• Cirrhosis or liver cancer
• Kidney failure (hepatorenal syndrome)
• Bleeding disorders due to impaired clotting

Lifestyle & Prevention

• Practice safe sex (use condoms) to reduce transmission risk.
• Avoid sharing needles or personal items that may contact blood.
• Ensure vaccination against hepatitis B for at-risk individuals.
• Follow hygiene practices, especially in healthcare settings.
• Avoid alcohol and hepatotoxic medications to reduce liver stress.
• Screen pregnant individuals for HBV to prevent perinatal transmission.

When to Seek Professional Help

Seek immediate medical attention if you experience symptoms of hepatic coma (e.g., confusion, drowsiness, or loss of consciousness), severe abdominal pain, or jaundice. Prompt evaluation is critical for managing acute liver failure and preventing life-threatening complications.

Tips for Medical Coders

Document the presence of hepatic coma and confirm the absence of delta-agent (HDV) co-infection to support the B16.2 code. Include clinical details such as liver function test results, viral serology, and any interventions (e.g., antivirals, transplantation) to ensure accurate coding and reflect the severity of the condition.